Kinnate Biopharma Inc.
Inhibitors of RAF kinases
Last updated:
Abstract:
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Status:
Grant
Type:
Utility
Filling date:
23 Oct 2020
Issue date:
24 Aug 2021